Cargando…

N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models

BACKGROUND: Diabetic nephropathy (DN) is a late complication in both type 1 diabetes mellitus (T1DM) and T2DM. Already at an early stage of DN morphological changes occur at the cell surface and in the extracellular matrix where the majority of the proteins carry N-linked glycosylations. These glyco...

Descripción completa

Detalles Bibliográficos
Autores principales: Liljedahl, Leena, Pedersen, Maiken Højgaard, Norlin, Jenny, McGuire, James N., James, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065702/
https://www.ncbi.nlm.nih.gov/pubmed/27757071
http://dx.doi.org/10.1186/s12014-016-9123-z
_version_ 1782460360592195584
author Liljedahl, Leena
Pedersen, Maiken Højgaard
Norlin, Jenny
McGuire, James N.
James, Peter
author_facet Liljedahl, Leena
Pedersen, Maiken Højgaard
Norlin, Jenny
McGuire, James N.
James, Peter
author_sort Liljedahl, Leena
collection PubMed
description BACKGROUND: Diabetic nephropathy (DN) is a late complication in both type 1 diabetes mellitus (T1DM) and T2DM. Already at an early stage of DN morphological changes occur at the cell surface and in the extracellular matrix where the majority of the proteins carry N-linked glycosylations. These glycosylated proteins are highly important in cell adhesion and cell–matrix processes but not much is known about how they change in DN or whether the distinct etiology of T1DM and T2DM could have an effect on their abundances. METHOD: We enriched for the N-glycosylated kidney proteome in db/db mice dosed with insulin or vehicle, in streptozotocin-induced (STZ) diabetic mice and healthy control mice dosed with vehicle. Glycopeptides were analyzed with label-free shotgun mass spectrometry and differential protein abundances identified in both mouse models were compared using multivariate analyses. RESULTS: The majority of the N-glycosylated proteins were similarly regulated in both mouse models. However, distinct differences between the two mouse models were for example seen for integrin-β1, a protein expressed mainly in the glomeruli which abundance was increased in the STZ diabetic mice while decreased in the db/db mice and for the sodium/glucose cotransporter-1, mainly expressed in the proximal tubules which abundance was increased in the db/db mice but decreased in the STZ diabetic mice. Insulin had an effect on the level of both glomerular and tubular proteins in the db/db mice. It decreased the abundance of G-protein coupled receptor-116 and of tyrosine-protein phosphatase non-receptor type substrate-1 away from the level in the healthy control mice. CONCLUSIONS: Our finding of differences in the N-glycosylation protein profiles in the db/db and STZ mouse models suggest that the etiology of DN could give rise to variations in the cell adhesion and cell–matrix composition in T1DM and T2DM. Thus, N-glycosylated protein differences could be a clue to dissimilarities in T1DM and T2DM at later stages of DN. Furthermore, we observed insulin specific regulation of N-glycosylated proteins both in the direction of and away from the abundances in healthy control mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12014-016-9123-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5065702
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50657022016-10-18 N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models Liljedahl, Leena Pedersen, Maiken Højgaard Norlin, Jenny McGuire, James N. James, Peter Clin Proteomics Research BACKGROUND: Diabetic nephropathy (DN) is a late complication in both type 1 diabetes mellitus (T1DM) and T2DM. Already at an early stage of DN morphological changes occur at the cell surface and in the extracellular matrix where the majority of the proteins carry N-linked glycosylations. These glycosylated proteins are highly important in cell adhesion and cell–matrix processes but not much is known about how they change in DN or whether the distinct etiology of T1DM and T2DM could have an effect on their abundances. METHOD: We enriched for the N-glycosylated kidney proteome in db/db mice dosed with insulin or vehicle, in streptozotocin-induced (STZ) diabetic mice and healthy control mice dosed with vehicle. Glycopeptides were analyzed with label-free shotgun mass spectrometry and differential protein abundances identified in both mouse models were compared using multivariate analyses. RESULTS: The majority of the N-glycosylated proteins were similarly regulated in both mouse models. However, distinct differences between the two mouse models were for example seen for integrin-β1, a protein expressed mainly in the glomeruli which abundance was increased in the STZ diabetic mice while decreased in the db/db mice and for the sodium/glucose cotransporter-1, mainly expressed in the proximal tubules which abundance was increased in the db/db mice but decreased in the STZ diabetic mice. Insulin had an effect on the level of both glomerular and tubular proteins in the db/db mice. It decreased the abundance of G-protein coupled receptor-116 and of tyrosine-protein phosphatase non-receptor type substrate-1 away from the level in the healthy control mice. CONCLUSIONS: Our finding of differences in the N-glycosylation protein profiles in the db/db and STZ mouse models suggest that the etiology of DN could give rise to variations in the cell adhesion and cell–matrix composition in T1DM and T2DM. Thus, N-glycosylated protein differences could be a clue to dissimilarities in T1DM and T2DM at later stages of DN. Furthermore, we observed insulin specific regulation of N-glycosylated proteins both in the direction of and away from the abundances in healthy control mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12014-016-9123-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-15 /pmc/articles/PMC5065702/ /pubmed/27757071 http://dx.doi.org/10.1186/s12014-016-9123-z Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liljedahl, Leena
Pedersen, Maiken Højgaard
Norlin, Jenny
McGuire, James N.
James, Peter
N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title_full N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title_fullStr N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title_full_unstemmed N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title_short N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
title_sort n-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065702/
https://www.ncbi.nlm.nih.gov/pubmed/27757071
http://dx.doi.org/10.1186/s12014-016-9123-z
work_keys_str_mv AT liljedahlleena nglycosylationproteomeenrichmentanalysisinkidneyrevealsdifferencesbetweendiabeticmousemodels
AT pedersenmaikenhøjgaard nglycosylationproteomeenrichmentanalysisinkidneyrevealsdifferencesbetweendiabeticmousemodels
AT norlinjenny nglycosylationproteomeenrichmentanalysisinkidneyrevealsdifferencesbetweendiabeticmousemodels
AT mcguirejamesn nglycosylationproteomeenrichmentanalysisinkidneyrevealsdifferencesbetweendiabeticmousemodels
AT jamespeter nglycosylationproteomeenrichmentanalysisinkidneyrevealsdifferencesbetweendiabeticmousemodels